Literature DB >> 9028689

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

P A Torjesen1, K I Birkeland, S A Anderssen, I Hjermann, I Holme, P Urdal.   

Abstract

OBJECTIVE: To compare and assess the single and joint effect of diet and exercise intervention for 1 year on insulin resistance and the development leading toward the insulin resistance syndrome. RESEARCH DESIGN AND METHODS: An unmasked, randomized 2 x 2 factorial intervention trial was applied with a duration of 1 year for each participant. The trial comprised 219 men and women with diastolic blood pressure of 86-99 mmHg, HDL cholesterol < 1.20 mmol/l, triglycerides > 1.4 mmol/l, total cholesterol of 5.20-7.74 mmol/l, and BMI > 24 kg/m2. Participants were randomly allocated to diet group (n = 35), diet and exercise group (n = 67), exercise group (n = 54), and control group (n = 43). The diet included increased intake of fish and reduced total fat intake. The exercise program entailed supervised endurance exercise three times a week. Baseline cross-sectional changes and 1-year changes in insulin resistance, fasting serum levels of insulin, C-peptide, proinsulin, glucose, and lipids as well as weight, mean blood pressure, and plasminogen activator inhibitor 1 (PAI-1) values were recorded.
RESULTS: The cross-sectional results at baseline showed significant correlations between the calculated insulin resistance and BMI (r = 0.54) and correlations between the mean blood pressure (mBP) (r = 0.26) and PAI-1 (r = 0.40). The 1-year diet intervention gave a significant decrease in the calculated insulin resistance from 4.6 to 4.2 and a positive correlation between the changes in insulin resistance and changes in BMI (r = 0.40). The diet and exercise intervention also led to significantly decreased insulin resistance (from 5.0 to 4.0). The exercise intervention did not significantly change insulin resistance.
CONCLUSIONS: The cross-sectional and 1-year intervention results supported each other and underscored the important connection between increased BMI and the development leading toward the insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028689     DOI: 10.2337/diacare.20.1.26

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  44 in total

Review 1.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  The epidemiology of lifestyle and risk for type 2 diabetes.

Authors:  Rob M van Dam
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Impact of the prevention plan on employee health risk reduction.

Authors:  Ronald Loeppke; Dee W Edington; Sami Bég
Journal:  Popul Health Manag       Date:  2010-10       Impact factor: 2.459

Review 4.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 5.  2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].

Authors:  David C W Lau; James D Douketis; Katherine M Morrison; Irene M Hramiak; Arya M Sharma; Ehud Ur
Journal:  CMAJ       Date:  2007-04-10       Impact factor: 8.262

6.  Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.

Authors:  H Hämäläinen; T Rönnemaa; A Virtanen; J Lindström; J G Eriksson; T T Valle; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Rastas; S Aunola; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

7.  Physical activity and metabolic syndrome among Ethiopian adults.

Authors:  Tsegaselassie Workalemahu; Bizu Gelaye; Yemane Berhane; Michelle A Williams
Journal:  Am J Hypertens       Date:  2013-02-19       Impact factor: 2.689

8.  Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.

Authors:  David J Leehey; Irfan Moinuddin; Joseph P Bast; Shahzad Qureshi; Christine S Jelinek; Cheryl Cooper; Lonnie C Edwards; Bridget M Smith; Eileen G Collins
Journal:  Cardiovasc Diabetol       Date:  2009-12-09       Impact factor: 9.951

Review 9.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

Review 10.  Preventing and managing cardiometabolic risk: the logic for intervention.

Authors:  Mark A Pereira; Thomas E Kottke; Courtney Jordan; Patrick J O'Connor; Nicolaas P Pronk; Rita Carreón
Journal:  Int J Environ Res Public Health       Date:  2009-09-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.